Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corneal Debridement for Traumatic Corneal Abrasion
NCT05534217Unknown
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Dec 2022
- Primary completion
- Sep 2023
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Zhongshan Ophthalmic Center. Primary endpoint: Wound Recurrence at 12 months. Status: unknown.
Beyond the preview
Go deeper on NCT05534217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05534217.